QIAstat-Dx BCID GPF Plus AMR Panel
Rapidly identify common bloodstream pathogens and AMR markers to support faster, more informed treatment decisions.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The QIAstat-Dx BCID GPF Plus AMR Panel is a multiplex syndromic test designed for rapid, comprehensive detection of bloodstream infection pathogens and associated antimicrobial resistance markers. It delivers actionable results directly from positive blood culture samples to support timely, targeted therapy decisions.
Comprehensive bloodstream infection coverage
This panel is optimized for broad detection of gram-positive bacteria, gram-negative bacteria, fungi, and key antimicrobial resistance determinants in a single run. It is intended for use with the QIAstat-Dx Analyzer, integrating sample processing, nucleic acid amplification, and detection in a closed, cartridge-based system to minimize hands-on time.
Streamlined workflow for clinical laboratories
The QIAstat-Dx BCID GPF Plus AMR Panel is designed to fit seamlessly into routine microbiology workflows, from sample loading to result interpretation. Automated processing reduces manual steps and variability, while standardized assay conditions support consistent performance across runs and operators.
Actionable results to support antimicrobial stewardship
By combining pathogen identification with detection of critical antimicrobial resistance markers, the panel helps clinicians refine empiric therapy and support antimicrobial stewardship initiatives. Rapid, syndromic results can aid in optimizing patient management, improving laboratory efficiency, and supporting infection control strategies.
Key features and benefits of QIAstat-Dx BCID GPF Plus AMR Panel:
- Multiplex syndromic panel for broad detection of bloodstream infection pathogens
- Integrated workflow on the QIAstat-Dx Analyzer for minimal hands-on time
- Simultaneous identification of organisms and antimicrobial resistance markers
- Closed, cartridge-based system to reduce contamination risk
- Supports faster, more informed antimicrobial therapy decisions
